Literature DB >> 12488709

The epidemiology of hepatitis C virus infection.

Tommy Yen1, Emmet B Keeffe, Aijaz Ahmed.   

Abstract

The prevalence of hepatitis C virus (HCV) infection varies in different populations, ranging from as low as 0.6% in volunteer blood donors to as high as 80% in injection drug users. The prevalence of HCV in a population can be predicted by risk factors associated with the transmission of infection. These risk factors include injection drug use, blood product transfusion, organ transplantation, hemodialysis, occupational injury, sexual transmission, and vertical transmission. We review the literature regarding the incidence and prevalence of HCV infection and the evidence supporting various modes of HCV transmission.

Entities:  

Mesh:

Year:  2003        PMID: 12488709     DOI: 10.1097/00004836-200301000-00015

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  21 in total

1.  Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.

Authors:  M Zehairy; E Soliman; A Daghaidy
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

2.  Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE).

Authors:  Farzana Kapadia; Mary H Latka; Holly Hagan; Elizabeth T Golub; Jennifer V Campbell; Micaela H Coady; Richard S Garfein; David L Thomas; Sebastian Bonner; Thelma Thiel; Steffanie A Strathdee
Journal:  J Urban Health       Date:  2007-01       Impact factor: 3.671

Review 3.  Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-02-06

Review 4.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-09

5.  Alcohol-related and viral hepatitis C-related cirrhosis mortality among Hispanic subgroups in the United States, 2000-2004.

Authors:  Young-Hee Yoon; Hsiao-ye Yi; Patricia C Thomson
Journal:  Alcohol Clin Exp Res       Date:  2010-12-01       Impact factor: 3.455

6.  Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections.

Authors:  T Eleftheriadis; V Liakopoulos; K Leivaditis; G Antoniadi; I Stefanidis
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

7.  Prevalence of hepatitis C infection in a population of asymptomatic people in a checkup unit in Mexico city.

Authors:  Nahum Méndez-Sánchez; Guadalupe Ponciano-Rodriguez; Norberto C Chávez-Tapia; Daniel Motola-Kuba; Paloma Almeda-Valdes; Karla Sánchez-Lara; Martha H Ramos; Misael Uribe
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

8.  Known and probable risk factors for hepatitis C infection: a case series in north-eastern Poland.

Authors:  Sławomir Chlabicz; Robert Flisiak; Anna Grzeszczuk; Oksana Kovalchuk; Danuta Prokopowicz; Lech Chyczewski
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

Review 9.  Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosis.

Authors:  Hosam Zaghloul; Mahmoud El-Shahat
Journal:  World J Hepatol       Date:  2014-12-27

Review 10.  Viral hepatitis: new data on hepatitis C infection.

Authors:  Erzsébet Szabó; Gábor Lotz; Csilla Páska; András Kiss; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.